World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
169
Citations
106507
World Ranking
913
National Ranking
540

Medicine

D-Index
169
Citations
108378
World Ranking
543
National Ranking
320

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Bart Barlogie is affiliated with Mount Sinai Hospital in the United States. Their research primarily focuses on medicine, with a significant number of publications in biochemistry, genetics, and molecular biology. Within these fields, Barlogie specializes in hematology, molecular biology, oncology, pathology and forensic medicine, and immunology.

Barlogie's work centers on several main topics, including multiple myeloma research and treatments, protein degradation and inhibitors, peptidase inhibition and analysis, cancer treatment and pharmacology, cancer mechanisms and therapy, chemokine receptors and signaling, and cancer genomics and diagnostics.

Barlogie has published extensively in several scientific venues, with frequent contributions to:

  • Blood
  • Blood Advances
  • Clinical Lymphoma Myeloma & Leukemia
  • Nature Communications
  • Blood Cancer Journal

Some recent papers associated with Barlogie include the following:

  • "Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)", 2020, Blood Cancer Journal
  • "The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma", 2021, Nature Communications
  • "Long-term outcomes after autologous stem cell transplantation for multiple myeloma", 2020, Blood Advances
  • "Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials", 2020, PLoS Medicine
  • "The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states", 2022, Nature Communications

Barlogie frequently collaborates with several researchers, including:

  • Frits van Rhee
  • Maurizio Zangari
  • Carolina Schinke
  • Sharmilan Thanendrarajan
  • John D. Shaughnessy

The scientist has been recognized as a member of the Association of American Physicians. Their research contributions span multiple disciplines and address complex aspects of multiple myeloma and cancer biology.

Best Publications

  • Antitumor activity of thalidomide in refractory multiple myeloma.

    S Singhal;J Mehta;R Desikan;D Ayers

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • A phase 2 study of bortezomib in relapsed, refractory myeloma.

    Paul G. Richardson;Bart Barlogie;James Berenson;Seema Singhal

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

    Erming Tian;Fenghuang Zhan;Ronald Walker;Erik Rasmussen

  • The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

    Christina M. Annunziata;R. Eric Davis;Yulia Demchenko;William Bellamy

  • A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    John D. Shaughnessy;Fenghuang Zhan;Bart E. Burington;Yongsheng Huang

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

    S. Jagannath;B. Barlogie;J. Berenson;D. Siegel

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    Brian G.M. Durie;Antje Hoering;Muneer H. Abidi;S. Vincent Rajkumar

  • Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents

    Bart Barlogie;Lon Smith;Raymond Alexanian

  • Genetics and Cytogenetics of Multiple Myeloma A Workshop Report

    Rafael Fonseca;Bart Barlogie;Regis Bataille;Christian Bastard

  • Thalidomide and hematopoietic-cell transplantation for multiple myeloma

    Bart Barlogie;Guido Tricot;Elias Anaissie;John Shaughnessy

  • Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

    P. Leif Bergsagel;W. Michael Kuehl;Fenghuang Zhan;Jeffrey Sawyer

  • Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

    Fenghuang Zhan;Johanna S. Hardin;Bob Kordsmeier;Klaus Bumm

Frequent Co-Authors

Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
John D. Shaughnessy
John D. Shaughnessy University of Arkansas for Medical Sciences
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences
Maurizio Zangari
Maurizio Zangari University of Arkansas for Medical Sciences
John Crowley
John Crowley Washington University in St. Louis
Elias Anaissie
Elias Anaissie University of Cincinnati
Guido Tricot
Guido Tricot University of Iowa
Gareth J. Morgan
Gareth J. Morgan Boston University
Saad Z. Usmani
Saad Z. Usmani Memorial Sloan Kettering Cancer Center
Faith E. Davies
Faith E. Davies New York University Langone Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a wide range of related healthcare careers and online degrees. For registered nurses seeking career growth, adn to fnp bridge programs provide a flexible route to becoming a family nurse practitioner, often allowing you to balance work and study.

If you have a passion for nutrition and public health, a best online nutrition degree can prepare you for diverse roles in wellness, dietetics, or health education. Online options make it possible to gain accredited credentials without relocating or commuting.

Management and leadership in healthcare are also in high demand. Earning one of the top online mha programs that are cahme accredited can help position you for roles as a healthcare administrator or executive, enhancing your ability to impact patient care at the organizational level.

For those looking to enhance their RN qualifications with academic advancement, consider an rn to bsn with no clinicals program. These streamlined pathways are perfect for working nurses seeking career mobility in less hands-on settings.

Best Scientists Citing Bart Barlogie

Trending Scientists